HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antipsychotic monotherapy and adjuvant psychotropic therapies in schizophrenia patients: effect on time to readmission.

Abstract
This study assessed the relationship between pharmacological regimens at hospital discharge and hospital readmission among schizophrenia patients. The records reviewed were all consecutive admissions (N=720) from a specific catchment area during the period 1991-2005. Two main groups were selected for analysis: the first group (N=537) included patients discharged with first-generation antipsychotics (FGA), and the second group (N=183) included patients with second-generation antipsychotics (SGA). Data on clinical and demographic characteristics at discharge, including a brief psychiatric rating scale and pharmacological treatment, were collected. The rate of readmission within 12 months was analyzed in relation to the specific pharmacological treatment at discharge. There was no significant difference in the risk of readmission in patients treated with SGA compared with FGA. Adjuvant psychotropic medications to either FGA or SGA did not attenuate the risk of readmission. The readmission rate in patients treated with clozapine (N=74) was significantly lower in comparison with depot FGA (N=293) medications (P=0.016). There was no advantage of SGA over FGA, with or without adjuvant psychotropic treatment, with regard to rehospitalization risk during the 12-month follow-up. Clozapine was found to reduce the risk for readmission in comparison with depot FGA.
AuthorsAvi Valevski, Yaron Gilat, Mark Olfson, Noa Benaroya-Milshtein, Abraham Weizman
JournalInternational clinical psychopharmacology (Int Clin Psychopharmacol) Vol. 27 Issue 3 Pg. 159-64 (May 2012) ISSN: 1473-5857 [Electronic] England
PMID22466059 (Publication Type: Journal Article)
Chemical References
  • Antipsychotic Agents
  • Delayed-Action Preparations
  • Psychotropic Drugs
  • Clozapine
Topics
  • Adult
  • Antipsychotic Agents (therapeutic use)
  • Clozapine (therapeutic use)
  • Delayed-Action Preparations
  • Drug Therapy, Combination
  • Female
  • Humans
  • Israel
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Patient Discharge
  • Patient Readmission
  • Proportional Hazards Models
  • Psychiatric Status Rating Scales
  • Psychotropic Drugs (therapeutic use)
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Schizophrenia (diagnosis, drug therapy, mortality)
  • Schizophrenic Psychology
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: